Efficacy of combined therapy and maintenance treatment with intranasal glucocorticoid on allergic rhinitis

ZHANG Ke,KE Jia,MA Furong,ZHANG Yinghong,WANG Lin,ZHAO Jianhui,XIE Lifeng,LU Peiquan,ZHAO Yanping,XU Jia,ZHU Li

DOI: https://doi.org/10.16066/j.1672-7002.2010.11.017

2010-01-01

Abstract:OBJECTIVE To evaluate the effect and quality of life of combined therapy and maintenance treatment with intranasal glucocorticoid on allergic rhinitis.METHODS Budesonide and loratadine were given to 24 patients with moderate to severe persistent allergic rhinitis for 1 week.Eighteen patients who presented an improvement of symptom score were randomly divided into 11 cases of maintenance treatment with budesonide as experimental group and 7 patients without any drug as control group.Clinical symptom score,visual analogue scale(VAS)and rhinoconjunctivitis quality of life questionnaire(RQLQ)were observed during this period.RESULTS After combined therapy for 1 week,clinical symptoms and quality of life were significantly improved(P<0.01).There were effective after treatment in 91.7% cases(22/24).After maintenance treatment for 1 month,the symptom score was significantly higher than the end of combined therapy for both experimental group and control group(P<0.01).The score of VAS and RQLQ were also higher than the end of combined therapy,but no significant differences were found.There was no significant difference between the two groups.CONCLUSION Combined therapy could relieve the symptoms effectively,and succeeding maintenance treatment with intranasal glucocorticoid could improve the quality of life for moderate to severe persistent allergic rhinitis.